Detalhe da pesquisa
1.
Respiratory syncytial virus vs. Influenza virus infection: mortality and morbidity comparison over 7 epidemic seasons in an elderly population.
J Infect Dis
; 2024 Apr 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-38574192
2.
Clinical description of the broad range of neurological presentations of COVID-19: A retrospective case series.
Rev Neurol (Paris)
; 177(3): 275-282, 2021 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-33610347
3.
Pathogen identification by shotgun metagenomics of patients with necrotizing soft-tissue infections.
Br J Dermatol
; 183(1): 105-113, 2020 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-31610037
4.
Multicenter Evaluation of the Cepheid Xpert Hepatitis C Virus Viral Load Assay.
J Clin Microbiol
; 55(5): 1550-1556, 2017 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-28275079
5.
Performance of rapid diagnostic tests for the detection of antibodies to hepatitis C virus in whole blood collected on dried blood spots.
J Viral Hepat
; 23(5): 399-401, 2016 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-26833561
6.
Association between IL28B polymorphism, TNFα and biomarkers of insulin resistance in chronic hepatitis C-related insulin resistance.
J Viral Hepat
; 22(11): 890-6, 2015 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-25818002
7.
A practical guide for the use of boceprevir and telaprevir for the treatment of hepatitis C.
J Viral Hepat
; 19 Suppl 2: 1-26, 2012 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-22404758
8.
IL28B polymorphisms predict reduction of HCV RNA from the first day of therapy in chronic hepatitis C.
J Hepatol
; 55(5): 980-8, 2011 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-21354446
9.
Microdiversity of Enterococcus faecalis isolates in cases of infective endocarditis: selection of non-synonymous mutations and large deletions is associated with phenotypic modifications.
Emerg Microbes Infect
; 10(1): 929-938, 2021 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-33913790
10.
Prediction of nonSVR to therapy with pegylated interferon-alpha2a and ribavirin in chronic hepatitis C genotype 1 patients after 4, 8 and 12 weeks of treatment.
J Viral Hepat
; 17(5): 345-51, 2010 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-19780947
11.
[The liver and Europe]. / Le foie et l'Europe.
Gastroenterol Clin Biol
; 33(8-9): 903-7, 2009.
Artigo
em Francês
| MEDLINE | ID: mdl-19720485
12.
Interferon and ribavirin therapy does not select for resistance mutations in hepatitis C virus polymerase.
J Viral Hepat
; 15(8): 571-7, 2008 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-18363671
13.
[Virologic techniques for the diagnosis and monitoring of hepatitis B]. / Les techniques virologiques de diagnostic et de suivi de l'hépatite B.
Gastroenterol Clin Biol
; 32(1 Pt 2): S56-63, 2008 Jan.
Artigo
em Francês
| MEDLINE | ID: mdl-18662611
14.
Viral kinetics analysis and virological characterization of treatment failures in patients with chronic hepatitis C treated with sofosbuvir and an NS5A inhibitor.
Aliment Pharmacol Ther
; 47(5): 665-673, 2018 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-29271114
15.
Hepatitis C virus population dynamics during infection.
Curr Top Microbiol Immunol
; 299: 261-84, 2006.
Artigo
em Inglês
| MEDLINE | ID: mdl-16568902
16.
Prospective assessment of rapid diagnostic tests for the detection of antibodies to hepatitis C virus, a tool for improving access to care.
Clin Microbiol Infect
; 22(5): 459.e1-6, 2016 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-26806260
17.
Multicenter clinical evaluation of the new 3rd generation assay for detection of antibodies against hepatitis C virus on the VIDAS(®) system.
J Clin Virol
; 78: 20-6, 2016 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-26962723
18.
Identification of a duplicated V3 domain in NS5A associated with cirrhosis and hepatocellular carcinoma in HCV-1b patients.
J Clin Virol
; 69: 203-9, 2015 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-26209408
19.
Activity of the interferon-induced 2',5'-oligoadenylate synthetase in patients with chronic hepatitis C.
J Interferon Cytokine Res
; 15(10): 857-62, 1995 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-8564707
20.
Molecular tools for the treatment of hepatitis C.
Antivir Ther
; 3(Suppl 3): 45-55, 1998.
Artigo
em Inglês
| MEDLINE | ID: mdl-10726055